Mar 20, 2023 | Clinical Trial News, Company News, Uncategorized
Milan, Italy | Exom Group is proud to be part of the Geremy project – a project seeking a genetic cure for inherited arrhythmogenic cardiomyopathy (ACM), a rare cardiac disease – funded by the European Union as part of the Horizon 2022 program. We are joining forces...
Nov 14, 2022 | Company News, Genius Engage, Genius Suite
Genius vENGAGE: The Remote Verbal Consent for a Patient-Centric Clinical Trial Exom Group, a Clinscience company, is proud to announce the release of the first patient-centric “reliable & compliant” remote verbal consent for clinical trials (Genius vENGAGE). The...
Jul 14, 2022 | Clinical Trial News, Company News
ASCO Annual Meeting 2022 During the first week of June, we witnessed the opening of the annual meeting of the American Society of Clinical Oncology (ASCO) for the first time since 2019. ASCO is known as the world’s leading Oncology event that brings together...
May 11, 2022 | Clinical Trial News, Company News
The Global CRO pursues further development in the digitalization of Clinical Research Clinscience US LLC, a subsidiary of Neuca Group, on 26th of April signed an investment agreement to acquire 51% of shares in Agati Systems. The US-based (Texas) Company, together...
Jan 15, 2022 | Company News, Genius Suite
Exom is proud to announce to being awarded the GHP Global Excellence Award by Global Health & Pharma as “Most Innovative Full-Service CRO – 2022” for our pioneering and cutting-edge use of technology (with our Genius SUITE™) in clinical trials to...
Aug 3, 2021 | Articles, Case Study, Clinical Trial News, Company News
Having made a name for itself as the ‘Most Innovative Full-Service CRO’ for 2021, the Exom Group has been pushing for the acceptance of digital and technological solutions in Clinical Trials. Whilst there is still a lot of work to be done before the field embraces the...
